Yousif Capital Management LLC Sells 3,380 Shares of Unum Group (NYSE:UNM)

Yousif Capital Management LLC cut its holdings in shares of Unum Group (NYSE:UNM - Free Report) by 5.1% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 62,716 shares of the financial services provider's stock after selling 3,380 shares during the quarter. Yousif Capital Management LLC's holdings in Unum Group were worth $4,580,000 at the end of the most recent quarter.

Other large investors have also recently made changes to their positions in the company. Charles Schwab Investment Management Inc. raised its stake in shares of Unum Group by 1.0% during the third quarter. Charles Schwab Investment Management Inc. now owns 5,500,508 shares of the financial services provider's stock worth $326,950,000 after acquiring an additional 55,014 shares in the last quarter. Franklin Resources Inc. raised its stake in shares of Unum Group by 50.0% during the third quarter. Franklin Resources Inc. now owns 469,342 shares of the financial services provider's stock worth $29,554,000 after acquiring an additional 156,380 shares in the last quarter. Blue Trust Inc. raised its stake in shares of Unum Group by 44.1% during the fourth quarter. Blue Trust Inc. now owns 16,495 shares of the financial services provider's stock worth $1,205,000 after acquiring an additional 5,047 shares in the last quarter. Thrivent Financial for Lutherans raised its stake in shares of Unum Group by 89.5% during the third quarter. Thrivent Financial for Lutherans now owns 111,831 shares of the financial services provider's stock worth $6,647,000 after acquiring an additional 52,813 shares in the last quarter. Finally, Kovitz Investment Group Partners LLC bought a new position in shares of Unum Group in the third quarter worth approximately $1,074,000. 86.57% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at Unum Group

In other Unum Group news, Director Hanley Ronald P. O sold 14,299 shares of the business's stock in a transaction dated Thursday, November 14th. The stock was sold at an average price of $72.10, for a total value of $1,030,957.90. Following the completion of the transaction, the director now owns 38,819 shares of the company's stock, valued at approximately $2,798,849.90. The trade was a 26.92 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Timothy Gerald Arnold sold 10,000 shares of the business's stock in a transaction dated Wednesday, November 27th. The stock was sold at an average price of $76.92, for a total value of $769,200.00. Following the completion of the transaction, the executive vice president now directly owns 54,827 shares of the company's stock, valued at approximately $4,217,292.84. This trade represents a 15.43 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 98,164 shares of company stock valued at $7,346,040 in the last quarter. 0.93% of the stock is owned by insiders.

Unum Group Stock Down 1.7 %

Shares of UNM stock traded down $1.32 during mid-day trading on Tuesday, reaching $75.24. 1,005,663 shares of the company's stock traded hands, compared to its average volume of 1,127,095. Unum Group has a 12 month low of $47.65 and a 12 month high of $79.43. The company has a market cap of $13.74 billion, a P/E ratio of 7.94, a P/E/G ratio of 1.17 and a beta of 0.80. The company has a quick ratio of 0.28, a current ratio of 0.29 and a debt-to-equity ratio of 0.32. The company's 50-day moving average price is $74.21 and its 200-day moving average price is $65.80.

Unum Group (NYSE:UNM - Get Free Report) last announced its earnings results on Tuesday, February 4th. The financial services provider reported $2.03 EPS for the quarter, missing analysts' consensus estimates of $2.14 by ($0.11). Unum Group had a net margin of 13.81% and a return on equity of 14.91%. On average, equities analysts expect that Unum Group will post 9.12 earnings per share for the current fiscal year.

Unum Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Friday, January 24th will be given a $0.42 dividend. This represents a $1.68 annualized dividend and a dividend yield of 2.23%. The ex-dividend date is Friday, January 24th. Unum Group's dividend payout ratio is presently 17.74%.

Wall Street Analysts Forecast Growth

Several research analysts have recently issued reports on the stock. Evercore ISI upgraded shares of Unum Group from an "in-line" rating to an "outperform" rating and raised their target price for the stock from $67.00 to $84.00 in a report on Thursday, November 14th. StockNews.com cut shares of Unum Group from a "buy" rating to a "hold" rating in a report on Thursday, February 6th. Barclays raised their target price on shares of Unum Group from $76.00 to $85.00 and gave the stock an "overweight" rating in a report on Monday, January 6th. Truist Financial lifted their price target on shares of Unum Group from $70.00 to $75.00 and gave the company a "buy" rating in a report on Friday, November 1st. Finally, BMO Capital Markets started coverage on shares of Unum Group in a report on Thursday, January 23rd. They issued an "outperform" rating and a $91.00 price target on the stock. Five research analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. According to data from MarketBeat, Unum Group presently has an average rating of "Moderate Buy" and a consensus target price of $79.45.

Unum Group Profile

Unum Group, together with its subsidiaries, provides financial protection benefit solutions primarily in the United States, the United Kingdom, Poland, and internationally. It operates through Unum US, Unum International, Colonial Life, and Closed Block segment. The company offers group long-term and short-term disability, group life, and accidental death and dismemberment products; supplemental and voluntary products, such as individual disability, voluntary benefits, and dental and vision products; and accident, sickness, disability, life, and cancer and critical illness products.